48-wk Open Label Phase IIIb to Evaluate Efficacy and Safety
NCT00654602 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1500
Last updated 2009-05-28
Summary
The purpose of this study is to assess the efficacy and safety of rosuvastatin in reducing low density lipoprotein cholesterol levels to internationally recognised goals in subjects with dyslipidaemia.
Conditions
- Dyslipidaemia
Interventions
- DRUG
-
Rosuvastatin
- BEHAVIORAL
-
Maintenance of specific diet
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Dr. Evan Stein · Metabolic & Athersclerotic research centre, USA
-
Russell Esterline · AstraZeneca
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2002-02-28
- Completion
- 2004-11-30
More Related Trials
-
Rosuvastatin Versus Atorvastatin in the Treatment of Hypercholesterolaemia in African American Subjects(ARIES)
NCT00653744 ·Status: COMPLETED ·Phase: PHASE3
-
A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)
NCT00240318 ·Status: COMPLETED ·Phase: PHASE3
-
Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease
NCT00329160 ·Status: COMPLETED ·Phase: PHASE4
-
Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy
NCT00239330 ·Status: COMPLETED ·Phase: PHASE3
-
A Study in Healthy Male Subjects to Investigate Whether Administration of ACT-541468 Can Affect the Fate in the Body (Amount and Time of Presence in the Blood) of Rosuvastatin
NCT03339752 ·Status: COMPLETED ·Phase: PHASE1
-
STELLAR-Rosuvastatin vs. Atorvastatin, Pravastatin, Simvastatin Across Dose Ranges
NCT00654537 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Rosuvastatin on the, in Vivo, Kinetic of apoB and apoA1, Using Stable Isotopes, in Type 2 Diabetic Patients
NCT00658463 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Rosuvastatin Therapy on HDL2 Level
NCT02593487 ·Status: UNKNOWN ·Phase: PHASE4
-
Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)
NCT00654225 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)
NCT00660764 ·Status: COMPLETED
-
A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects
NCT01101568 ·Status: COMPLETED ·Phase: PHASE1
-
A Diabetes Study to Treat A Population Previously Not at Target
NCT00747149 ·Status: COMPLETED ·Phase: PHASE4
-
Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants
NCT03806101 ·Status: COMPLETED ·Phase: PHASE1
-
Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia
NCT00683618 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Estimate the Effect of AZD5718 on the Pharmacokinetics (What Does the Body Does to the Drug) of Rosuvastatin to Measure the Relative Bioavailability (the Extent to Which a Drug or Other Substance Becomes Available to the Body) of AZD5718 Oral Suspension vs AZD5718 Immediate Release Tablet
NCT02963116 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate How AZD4144 Affects the Pharmacokinetics of Rosuvastatin in Healthy Participants
NCT06925854 ·Status: COMPLETED ·Phase: PHASE1
-
Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease
NCT00235950 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy/Safety of Rosuvastatin+Ezetimibe in High Risk Patients With Primary Hypercholesterolemia/Mixed Dyslipidemia
NCT01420549 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men
NCT00549653 ·Status: COMPLETED ·Phase: PHASE1
-
Phase III Study of Rosuvastatin and Fenofibrate Versus Rosuvastatin in Mixed Dyslipidemia
NCT02262143 ·Status: COMPLETED ·Phase: PHASE3
-
Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks
NCT01218802 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Crestor® (Rosuvastatin) in Daily Practice
NCT00837083 ·Status: COMPLETED
-
Comparing the Efficacy and Safety of Rosuvastatin With Atorvastatin and Simvastatin (SOLAR)
NCT00654173 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)
NCT00574782 ·Status: COMPLETED
-
Registry On Efficacy and Safety Of Rosuvastatin, and Atorvastatin and Simvastatin In Hypercholesterolaemia
NCT01352897 ·Status: COMPLETED